Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Sumitomo reports novel hCNTF variant

Jan. 21, 1997

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Jan. 21, 1997

New anticonvulsants from Howard University

Jan. 21, 1997

BMS antidepressant chosen for important multiinstitutional trial

Jan. 20, 1997

Phase II trials begin on ICOS MS treatment

Jan. 20, 1997

Conclusion of Cephalon/Schering-Plough AD collaboration

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Japanese investigators isolate novel aminopeptidase inhibitor

Jan. 17, 1997

New dopamine receptor ligands reported by Roche

Jan. 17, 1997

Avonex update presented

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...